{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:46:23Z","timestamp":1788572783365,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["SAMRC-RFA-EMU-10-2020"],"award-info":[{"award-number":["SAMRC-RFA-EMU-10-2020"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rpth.2025.103266","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:16:45Z","timestamp":1763659005000},"page":"103266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology, fibrinogen, clot properties, and cardiovascular disease risk\u2014an African perspective"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2849-6370","authenticated-orcid":false,"given":"Marlien","family":"Pieters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelda","family":"de Lange-Loots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.rpth.2025.103266_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ari\u00ebns","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/th14-02-0184","article-title":"Clot properties and cardiovascular disease","volume":"112","author":"Bridge","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice","volume":"119","author":"Z\u0105bczyk","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.rpth.2025.103266_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-030-58971-4_15","article-title":"Fibrinogen and fibrin","volume":"96","author":"Litvinov","year":"2021","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.rpth.2025.103266_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/ATVBAHA.119.313626","article-title":"Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis: a systematic review","volume":"40","author":"de Vries","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib6","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1182\/blood-2010-11-316885","article-title":"Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice","volume":"117","author":"Machlus","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib7","first-page":"135","article-title":"Novel biomarkers for cardiovascular risk prediction","volume":"14","author":"Wang","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.rpth.2025.103266_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2004.07.019","article-title":"Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study","volume":"149","author":"Wattanakit","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2025.103266_bib9","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Fibrinogen Studies Collaborations","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103266_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Emerging Risk Factors Collaborations","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103266_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.106.634089","article-title":"Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events","volume":"114","author":"Mora","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103266_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2141.2009.07778.x","article-title":"Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study","volume":"146","author":"Woodward","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103266_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015041","article-title":"Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study","volume":"7","author":"Yang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2025.103266_bib14","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.ATV.0000183937.65887.9c","article-title":"Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies","volume":"25","author":"Smith","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ije\/dyl114","article-title":"Fibrinogen and coronary heart disease: test of causality by \u2018Mendelian randomization\u2019","volume":"35","author":"Keavney","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.rpth.2025.103266_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/hmg\/ddv454","article-title":"A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration","volume":"25","author":"de Vries","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.matbio.2016.10.005","article-title":"Candidate gene analysis of the fibrinogen phenotype reveals the importance of polygenic co-regulation","volume":"60\u201361","author":"Cronj\u00e9","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/CIRCULATIONAHA.113.002251","article-title":"Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease","volume":"128","author":"Sabater-Lleal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103266_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216222","article-title":"Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease","volume":"14","author":"Ward-Caviness","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103266_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103266_bib21","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.jtha.2023.08.014","article-title":"Fibrinogen and fibrin: synthesis, structure, and function in health and disease","volume":"21","author":"Wolberg","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2009.04.019","article-title":"The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries","volume":"158","author":"Teo","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2025.103266_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048881","article-title":"Plasma clot lysis time and its association with cardiovascular risk factors in black Africans","volume":"7","author":"de Lange","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103266_bib24","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels","volume":"106","author":"Uitte de Willige","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib25","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1160\/TH11-03-0192","article-title":"Fibrinogen concentration and its role in CVD risk in black South Africans\u2014effect of urbanisation","volume":"106","author":"Pieters","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mnfr.200700373","article-title":"Nutrition and hemostasis: a focus on urbanization in South Africa","volume":"52","author":"Pieters","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.rpth.2025.103266_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/146642400312400112","article-title":"Some puzzling situations in the onset, occurrence and future of coronary heart disease in developed and developing populations, particularly such in sub-Saharan Africa","volume":"124","author":"Walker","year":"2004","journal-title":"J R Soc Promot Health"},{"key":"10.1016\/j.rpth.2025.103266_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1079\/PHN2001299","article-title":"The emergence of cardiovascular disease during urbanisation of Africans","volume":"5","author":"Vorster","year":"2002","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.rpth.2025.103266_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1613566","article-title":"Fibrin(ogen) in cardiovascular disease: an update","volume":"89","author":"Koenig","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jacc.2008.06.016","article-title":"Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study","volume":"52","author":"Jacquemin","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103266_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0049-3848(00)00197-3","article-title":"Nutritional status influences plasma fibrinogen concentration: evidence from the THUSA survey","volume":"98","author":"James","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103266_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MBC.0b013e328304b61a","article-title":"Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombin-antithrombin complex in African adolescents","volume":"19","author":"Nienaber","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2025.103266_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.304.6820.148","article-title":"Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life","volume":"304","author":"Barker","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103266_bib35","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1182\/blood-2012-12-471482","article-title":"Evidence that fibrinogen \u03b3' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans","volume":"121","author":"Pieters","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2016.09.010","article-title":"Fibrinogen splice variation and cross-linking: effects on fibrin structure\/function and role of fibrinogen \u03b3' as thrombomobulin II","volume":"60\u201361","author":"Duval","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2009.138347","article-title":"Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease","volume":"56","author":"Lovely","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.rpth.2025.103266_bib38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.thromres.2014.08.018","article-title":"CVD risk factors are related to plasma fibrin clot properties independent of total and or \u03b3' fibrinogen concentration","volume":"134","author":"Kotz\u00e9","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103266_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/hq0102.101552","article-title":"Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits","volume":"22","author":"Bastelica","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000073579","article-title":"The insulin resistance syndrome: implications for thrombosis and cardiovascular disease","volume":"32","author":"Juhan-Vague","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.rpth.2025.103266_bib41","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1016\/j.jacl.2024.08.004","article-title":"Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans","volume":"18","author":"Bruwer","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.rpth.2025.103266_bib42","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103266_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0039-1698460","article-title":"Interpretation and validation of maximum absorbance data obtained from turbidimetry analysis of plasma clots","volume":"120","author":"Pieters","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103487","article-title":"Plasma fibrin clot proteomics in healthy subjects: relation to clot permeability and lysis time","volume":"208","author":"Z\u0105bczyk","year":"2019","journal-title":"J Proteomics"},{"key":"10.1016\/j.rpth.2025.103266_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041966","article-title":"Identification of fibrin clot-bound plasma proteins","volume":"7","author":"Talens","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103266_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2019.02.001","article-title":"Plasma phospholipid fatty acids are associated with altered fibrin clot properties in a population-based setting","volume":"143","author":"de Lange","year":"2019","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.rpth.2025.103266_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH09-03-0187","article-title":"Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis","volume":"102","author":"Undas","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/ATVBAHA.109.195024","article-title":"Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation","volume":"30","author":"Barua","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2008.07569.x","article-title":"Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men","volume":"145","author":"Meltzer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103266_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12959-020-00249-4","article-title":"The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes","volume":"18","author":"Rautenbach","year":"2020","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.103266_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2014.04.021","article-title":"Relationship of coagulation and fibrinolytic variables with arterial structure and function in Africans","volume":"134","author":"Pieters","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103266_bib52","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/HJH.0000000000002204","article-title":"Plasminogen activator inhibitor-1 activity and the 4G\/5G polymorphism are prospectively associated with blood pressure and hypertension status","volume":"37","author":"Jacobs","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.rpth.2025.103266_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/a-1492-6143","article-title":"Lifestyle influences changes in fibrin clot properties over a 10-year period on a population level","volume":"122","author":"Swanepoel","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103266_bib54","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/ATVBAHA.107.153221","article-title":"Heritability of clot formation, morphology, and lysis: the EuroCLOT study","volume":"27","author":"Carter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.numecd.2022.12.011","article-title":"Association of the metabolic syndrome with PAI 1act and clot lysis time over a 10-year follow up in an African population","volume":"33","author":"Swanepoel","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.rpth.2025.103266_bib56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(09)60951-X","article-title":"The health and health system of South Africa: historical roots of current public health challenges","volume":"374","author":"Coovadia","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103266_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305826","article-title":"HIV infection and ART use are associated with altered plasma clot characteristics in Black South Africans","volume":"19","author":"Bakali","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103266_bib58","first-page":"35","article-title":"Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study","volume":"2","author":"Folsom","year":"1992","journal-title":"Ethn Dis"},{"key":"10.1016\/j.rpth.2025.103266_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood-2010-06-289546","article-title":"Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe)","volume":"117","author":"Wassel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib60","first-page":"133","article-title":"Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups","volume":"57","author":"Chen","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrg2731","article-title":"Methodological challenges of genome-wide association analysis in Africa","volume":"11","author":"Teo","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib62","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1182\/blood-2015-02-624551","article-title":"Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF","volume":"126","author":"Huffman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187712","article-title":"Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: independent and IL-6-interactive associations","volume":"12","author":"Cronj\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103266_bib64","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1749-6632.2001.tb03543.x","article-title":"Fibrinogen polymorphisms and atherothrombotic disease","volume":"936","author":"Green","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rpth.2025.103266_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/08820130902745153","article-title":"The functional effects of the -455G\/A polymorphism on the IL-6-induced expression of the beta-fibrinogen gene may be due to linkage disequilibrium with other functional polymorphisms","volume":"38","author":"Morozumi","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.rpth.2025.103266_bib66","doi-asserted-by":"crossref","first-page":"16763","DOI":"10.1074\/jbc.M501973200","article-title":"A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C\/T polymorphism","volume":"280","author":"Verschuur","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2025.103266_bib67","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bjh.13104","article-title":"Genetic polymorphisms influencing total and \u03b3' fibrinogen levels and fibrin clot properties in Africans","volume":"168","author":"Kotz\u00e9","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103266_bib68","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/01.ATV.19.12.3063","article-title":"Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration","volume":"19","author":"van\u2019t Hooft","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00202863","article-title":"Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster","volume":"94","author":"Baumann","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.93.3.440","article-title":"Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde","volume":"93","author":"Behague","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103266_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/humu.1380030117","article-title":"Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G\/A-455 (HaeIII), C\/T-148 (HindIII\/AluI), T\/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR","volume":"3","author":"Thomas","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2025.103266_bib72","doi-asserted-by":"crossref","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","article-title":"Ensembl 2016","volume":"44","author":"Yates","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.rpth.2025.103266_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10654-012-9666-x","article-title":"A genetic instrument for Mendelian randomization of fibrinogen","volume":"27","author":"Ken-Dror","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rpth.2025.103266_bib74","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(87)92557-8","article-title":"Genetic and cultural inheritance of plasma fibrinogen concentration","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103266_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-0004.1994.tb03997.x","article-title":"Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study","volume":"45","author":"Reed","year":"1994","journal-title":"Clin Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib76","first-page":"1194","article-title":"Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study","volume":"56","author":"Friedlander","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/(SICI)1096-8628(19960628)63:4<509::AID-AJMG1>3.0.CO;2-J","article-title":"Tel Aviv-Heidelberg three-generation offspring study: genetic determinants of plasma fibrinogen level","volume":"63","author":"Livshits","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib78","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.ATV.18.10.1559","article-title":"Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study","volume":"18","author":"Pankow","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.103266_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"de Lange","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103266_bib80","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/thg.2013.58","article-title":"Genetic architecture of the pro-inflammatory state in an extended twin-family design","volume":"16","author":"Neijts","year":"2013","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib81","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.2023022596","article-title":"Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles","volume":"144","author":"Huffman","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103266_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/b91ba224-10be-409d-93f4-7423d502cba0","article-title":"Power and predictive accuracy of polygenic risk scores","volume":"9","author":"Dudbridge","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.rpth.2025.103266_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2016.01.008","article-title":"Prospective study of \u03b3' fibrinogen and incident venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)","volume":"139","author":"Folsom","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103266_bib84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/rccm.200805-751OC","article-title":"Fibrinogen genes modify the fibrinogen response to ambient particulate matter","volume":"179","author":"Peters","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rpth.2025.103266_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.720048","article-title":"Certain associations between iron biomarkers and total and \u03b3' fibrinogen and plasma clot properties are mediated by fibrinogen genotypes","volume":"8","author":"Rautenbach","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.rpth.2025.103266_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.thromres.2015.01.015","article-title":"The contribution of genetic and environmental factors to changes in total and \u03b3' fibrinogen over 5 years","volume":"135","author":"Jobse","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103266_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.868542","article-title":"Associations between 25-hydroxyvitamin D and total and \u03b3' fibrinogen and plasma clot properties and gene interactions in a group of healthy Black South African women","volume":"9","author":"Rautenbach","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2025.103266_bib88","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jtha.2023.01.015","article-title":"DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood","volume":"21","author":"Hahn","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib89","first-page":"170","article-title":"Fibrin encapsulation of thrombin inside an arterial thrombus arrests the thrombotic response","volume":"9","author":"Yakusheva","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib90","first-page":"169","article-title":"Fibrin is a novel mediator of trained immunity-associated myeloid cell hypercoagulability [abstract]","volume":"9","author":"Rehill","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib91","first-page":"678","article-title":"Fibrinolysis resistance is associated with thrombosis in patients with end stage renal disease [abstract]","volume":"9","author":"Hunter Moore","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib92","first-page":"671","article-title":"Clot formation structure and fibrinolysis of pancreatic cancer patients [abstract]","volume":"9","author":"Risman","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib93","first-page":"650","article-title":"Disrupting the fibrin shield to combat Staphylococcus aureus bloodstream infections [abstract]","volume":"9","author":"Clark","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib94","first-page":"654","article-title":"Length of ischaemia duration is associated with fibrin film coverage of acute myocardial infarction [abstract]","volume":"9","author":"Ariens","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib95","first-page":"641","article-title":"Atomic force and scanning electron microscopy (AFM and SEM) imaging of fibrin fiber progression [abstract]","volume":"9","author":"Cai","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib96","first-page":"636","article-title":"Fluorescent peptide for detecting FXIIIa activity and fibrin in whole blood clots forming under flow","volume":"9","author":"Liu","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib97","first-page":"644","article-title":"Clot waveform analysis in Clauss assay contributes to classification of fibrinogen disorders [abstract]","volume":"9","author":"Wang","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103266_bib98","first-page":"174","article-title":"Internal lysis of contracted clots [abstract]","volume":"9","author":"Risman","year":"2025","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:31:55Z","timestamp":1768404715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2475037925005904"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103266","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, fibrinogen, clot properties, and cardiovascular disease risk\u2014an African perspective","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103266"}}